Works matching IS 15228517 AND DT 2023 AND VI 25 AND IP 2
Results: 28
Launch of an Editorial Scholars Program for Neuro-Oncology.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Society News.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 431, doi. 10.1093/neuonc/noad010
- Publication type:
- Article
Erratum to: Stereotactic targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
IDH-mutant glioma: A new IDH1 inhibitor moves forward.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 337, doi. 10.1093/neuonc/noac275
- By:
- Publication type:
- Article
Erratum to: Recovery from the damage of cranial radiation modulated by memantine, an NMDA receptor antagonist, combined with hyperbaric oxygen therapy.
- Published in:
- 2023
- Publication type:
- Correction Notice
Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 424, doi. 10.1093/neuonc/noac270
- By:
- Publication type:
- Article
Corrigendum to: Integrated longitudinal analysis of adult grade 4 diffuse gliomas with long-term relapse interval revealed upregulation of TGF-β signaling in recurrent tumors.
- Published in:
- 2023
- Publication type:
- Correction Notice
Digging deeper for new targets in bevacizumab resistance.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Response to "Intrathecal trastuzumab: What else do we need to consider?" by Gao et al.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 420, doi. 10.1093/neuonc/noac258
- By:
- Publication type:
- Article
Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 224, doi. 10.1093/neuonc/noac221
- By:
- Publication type:
- Article
Influence of county-level geographic/ancestral origin on glioma incidence and outcomes in US Hispanics.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 398, doi. 10.1093/neuonc/noac175
- By:
- Publication type:
- Article
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 339, doi. 10.1093/neuonc/noac173
- By:
- Publication type:
- Article
Commentary on "Dysfunctional dendritic cells limit antigen-specific T cell response in glioma".
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 277, doi. 10.1093/neuonc/noac256
- By:
- Publication type:
- Article
The NCI Glioblastoma Therapeutics Network (GTN).
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 221, doi. 10.1093/neuonc/noac247
- By:
- Publication type:
- Article
Characterizing the biology of primary brain tumors and their microenvironment via single-cell profiling methods.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 234, doi. 10.1093/neuonc/noac211
- By:
- Publication type:
- Article
Intrathecal trastuzumab: What else do we need to consider?
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 418, doi. 10.1093/neuonc/noac225
- By:
- Publication type:
- Article
Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 351, doi. 10.1093/neuonc/noac185
- By:
- Publication type:
- Article
Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 303, doi. 10.1093/neuonc/noac171
- By:
- Publication type:
- Article
Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactions.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 290, doi. 10.1093/neuonc/noac169
- By:
- Publication type:
- Article
Combined molecular subtyping, grading, and segmentation of glioma using multi-task deep learning.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 279, doi. 10.1093/neuonc/noac166
- By:
- Publication type:
- Article
Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 365, doi. 10.1093/neuonc/noac180
- By:
- Publication type:
- Article
DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 315, doi. 10.1093/neuonc/noac177
- By:
- Publication type:
- Article
Fastigial nuclei surgical damage and focal midbrain disruption implicate PAG survival circuits in cerebellar mutism syndrome.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 375, doi. 10.1093/neuonc/noac168
- By:
- Publication type:
- Article
Exposure to radon and heavy particulate pollution and incidence of brain tumors.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 407, doi. 10.1093/neuonc/noac163
- By:
- Publication type:
- Article
The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 326, doi. 10.1093/neuonc/noac155
- By:
- Publication type:
- Article
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 386, doi. 10.1093/neuonc/noac151
- By:
- Publication type:
- Article
Dysfunctional dendritic cells limit antigen-specific T cell response in glioma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 263, doi. 10.1093/neuonc/noac138
- By:
- Publication type:
- Article
Non-metabolic functions of phosphofructokinase-1 orchestrate tumor cellular invasion and genome maintenance under bevacizumab therapy.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 248, doi. 10.1093/neuonc/noac135
- By:
- Publication type:
- Article